[HTML][HTML] Microglia and astrocyte dysfunction in parkinson's disease

TI Kam, JT Hinkle, TM Dawson, VL Dawson - Neurobiology of disease, 2020 - Elsevier
While glia are essential for regulating the homeostasis in the normal brain, their dysfunction
contributes to neurodegeneration in many brain diseases, including Parkinson's disease …

GBA Variants and Parkinson Disease: Mechanisms and Treatments

L Smith, AHV Schapira - Cells, 2022 - mdpi.com
The GBA gene encodes for the lysosomal enzyme glucocerebrosidase (GCase), which
maintains glycosphingolipid homeostasis. Approximately 5–15% of PD patients have …

Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease

EM Rocha, B De Miranda, LH Sanders - Neurobiology of disease, 2018 - Elsevier
Parkinson's disease (PD) is a complex, chronic and progressive neurodegenerative
disease. While the etiology of PD is likely multifactorial, the protein α-synuclein is a central …

α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies

MX Henderson, JQ Trojanowski, VMY Lee - Neuroscience letters, 2019 - Elsevier
Over 20 years ago, the synaptic protein α-synuclein was identified as the primary component
of the Lewy bodies (LBs) that are a sine qua non of Parkinson's disease (PD). Since that …

Ambroxol for the treatment of patients with Parkinson disease with and without glucocerebrosidase gene mutations: a nonrandomized, noncontrolled trial

S Mullin, L Smith, K Lee, G D'Souza… - JAMA …, 2020 - jamanetwork.com
Importance Mutations of the glucocerebrosidase gene, GBA1 (OMIM606463), are the most
important risk factor for Parkinson disease (PD). In vitro and in vivo studies have reported …

Neuropathology of incidental Lewy body & prodromal Parkinson's disease

T Koeglsperger, SL Rumpf, P Schließer… - Molecular …, 2023 - Springer
Background Parkinson's disease (PD) is a progressive neurodegenerative disorder
associated with a loss of dopaminergic (DA) neurons. Despite symptomatic therapies, there …

Glucocerebrosidase and its relevance to Parkinson disease

J Do, C McKinney, P Sharma, E Sidransky - Molecular neurodegeneration, 2019 - Springer
Mutations in GBA1, the gene encoding the lysosomal enzyme glucocerebrosidase, are
among the most common known genetic risk factors for the development of Parkinson …

Activation of β-glucocerebrosidase reduces pathological α-synuclein and restores lysosomal function in Parkinson's patient midbrain neurons

JR Mazzulli, F Zunke, T Tsunemi, NJ Toker… - Journal of …, 2016 - Soc Neuroscience
Parkinson's disease (PD) is characterized by the accumulation of α-synuclein (α-syn) within
Lewy body inclusions in the nervous system. There are currently no disease-modifying …

Glucosylsphingosine promotes α-synuclein pathology in mutant GBA-associated Parkinson's disease

YV Taguchi, J Liu, J Ruan, J Pacheco… - Journal of …, 2017 - Soc Neuroscience
Glucocerebrosidase 1 (GBA) mutations responsible for Gaucher disease (GD) are the most
common genetic risk factor for Parkinson's disease (PD). Although the genetic link between …

The emerging role of the lysosome in Parkinson's disease

A Navarro-Romero, M Montpeyó, M Martinez-Vicente - Cells, 2020 - mdpi.com
Lysosomal function has a central role in maintaining neuronal homeostasis, and,
accordingly, lysosomal dysfunction has been linked to neurodegeneration and particularly to …